← PLAINS GP HOLDINGS LP
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Net Income (Loss) Attributable to Parent | $94.0m | ($731.0m) | $334.0m | $331.0m | ($568.0m) | $60.0m | $168.0m | $198.0m | $103.0m | $260.0m | |
| Cash used in investing activities - continuing operations | ($1.3b) | — | — | — | — | — | — | ($540.0m) | ($705.0m) | ($3.2b) | |
| Cash used in investing activities - discontinued operations | — | — | — | — | — | — | — | ($162.0m) | ($170.0m) | ($197.0m) | |
| Effect of translation adjustment - continuing operations | — | $4.0m | ($9.0m) | ($3.0m) | ($8.0m) | ($5.0m) | ($3.0m) | $3.0m | ($11.0m) | $14.0m | |
| Effect of translation adjustment - discontinued operations | — | — | — | — | — | — | — | ($3.0m) | $2.0m | $0 | |
| Income from discontinued operations, net of tax | — | — | — | — | — | — | — | ($192.0m) | ($231.0m) | ($383.0m) | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | — | ($192.0m) | ($231.0m) | $152.0m | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | ($192.0m) | ($231.0m) | $1.3b | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | — | — | — | — | — | — | — | ($192.0m) | ($231.0m) | $108.0m | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | — | — | — | — | — | — | — | ($192.0m) | ($231.0m) | $383.0m | |
| Net Income (Loss) Attributable to Noncontrolling Interest | $566.0m | $690.0m | $1.8b | $1.7b | ($1.9b) | $540.0m | $995.0m | $1.2b | $967.0m | $1.4b | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $660.0m | ($41.0m) | $2.1b | $2.1b | ($2.4b) | $600.0m | $1.2b | $1.4b | $1.1b | $1.7b | |
| Amortization of Intangible Assets | $44.0m | $54.0m | $66.0m | $76.0m | $90.0m | $122.0m | $254.0m | $308.0m | $266.0m | $280.0m | |
| Depreciation | $471.0m | $465.0m | $455.0m | $528.0m | $566.0m | $655.0m | $710.0m | $736.0m | $753.0m | $673.0m | |
| Depreciation, Depletion and Amortization | $495.0m | $628.0m | $521.0m | $604.0m | $656.0m | $777.0m | $968.0m | $1.1b | $1.0b | $953.0m | |
| Deferred Income Tax Expense (Benefit) | ($7.0m) | $909.0m | $236.0m | $64.0m | ($218.0m) | $62.0m | $162.0m | $44.0m | $9.0m | $91.0m | |
| Deferred income tax expense | ($7.0m) | $909.0m | $236.0m | $64.0m | ($218.0m) | $62.0m | $162.0m | $44.0m | $9.0m | $91.0m | |
| (Gains)/losses on asset sales, asset impairments and other, net (Note 7, Note 8) | ($20.0m) | $109.0m | ($114.0m) | $28.0m | $719.0m | $592.0m | $269.0m | ($152.0m) | $160.0m | ($54.0m) | |
| Gain (Loss) on Sale of Assets and Asset Impairment Charges | — | — | $114.0m | ($28.0m) | ($719.0m) | ($592.0m) | ($269.0m) | $152.0m | ($160.0m) | $54.0m | |
| Goodwill, Impairment Loss | — | — | — | — | $2.5b | $0 | $0 | — | — | — | |
| Share-based Payment Arrangement, Expense | $60.0m | $41.0m | $79.0m | $35.0m | $16.0m | $24.0m | $41.0m | $51.0m | $52.0m | $50.0m | |
| Equity Method Investment, Realized Gain (Loss) on Disposal | — | — | $200.0m | — | — | — | — | — | — | — | |
| Income (Loss) from Equity Method Investments | $195.0m | $290.0m | $375.0m | $388.0m | $355.0m | $274.0m | $403.0m | $369.0m | $452.0m | $382.0m | |
| Income Tax Expense (Benefit) | $78.0m | $937.0m | $302.0m | $176.0m | ($167.0m) | $112.0m | $246.0m | $189.0m | $204.0m | $92.0m | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $382.0m | $467.0m | |
| Operating Lease, Lease Income | — | — | — | — | — | $28.0m | $29.0m | $32.0m | $26.0m | $8.0m | |
| Other Nonoperating Income (Expense) | $33.0m | ($31.0m) | ($7.0m) | $24.0m | $39.0m | $19.0m | ($219.0m) | $102.0m | $17.0m | $21.0m | |
| Changes in operating assets and liabilities: | |||||||||||
| Additional Financial Items | |||||||||||
| (Gain)/loss on foreign currency revaluation | — | — | — | — | ($16.0m) | ($7.0m) | $41.0m | $8.0m | ($17.0m) | $13.0m | |
| Asset Retirement Obligation, Accretion Expense | — | — | $4.0m | $5.0m | $5.0m | $4.0m | $4.0m | $4.0m | $4.0m | $4.0m | |
| Borrowing under PAA term loan (Note 11) | — | — | — | — | — | — | — | $0 | $0 | $1.1b | |
| Cash paid for purchases of linefill | — | — | — | — | ($14.0m) | ($37.0m) | ($84.0m) | ($23.0m) | ($21.0m) | ($27.0m) | |
| Cash paid in connection with acquisitions, net of cash acquired (Note 8) | ($282.0m) | ($1.3b) | — | ($50.0m) | ($310.0m) | ($32.0m) | ($149.0m) | ($425.0m) | ($248.0m) | ($2.7b) | |
| Change in fair value of Preferred Distribution Rate Reset Option (Note 13) | ($30.0m) | ($13.0m) | $14.0m | — | ($20.0m) | ($14.0m) | $189.0m | ($58.0m) | $0 | $0 | |
| Distributions on earnings from unconsolidated entities | $216.0m | $304.0m | $422.0m | $401.0m | $472.0m | $431.0m | $488.0m | $458.0m | $505.0m | $486.0m | |
| Distributions paid to Class A shareholders (Note 12) | ($234.0m) | ($271.0m) | ($189.0m) | ($231.0m) | ($166.0m) | ($140.0m) | ($162.0m) | ($209.0m) | ($251.0m) | ($301.0m) | |
| Equity earnings in unconsolidated entities | ($195.0m) | ($290.0m) | ($375.0m) | ($388.0m) | ($355.0m) | ($274.0m) | ($403.0m) | ($369.0m) | ($452.0m) | ($382.0m) | |
| Equity-indexed compensation expense | $60.0m | $41.0m | $79.0m | $35.0m | $16.0m | $24.0m | $41.0m | $51.0m | $52.0m | $50.0m | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($8.0m) | $21.0m | $1.0m | $1.0m | $16.0m | $7.0m | ($41.0m) | ($8.0m) | $17.0m | ($13.0m) | |
| Gain on investments in unconsolidated entities, net (Note 8, Note 9) | — | — | — | — | — | ($2.0m) | ($346.0m) | ($28.0m) | ($15.0m) | ($31.0m) | |
| General and Administrative Expense | $282.0m | $280.0m | $320.0m | $302.0m | $276.0m | $298.0m | $330.0m | $356.0m | $387.0m | $348.0m | |
| Goodwill | $2.3b | $2.6b | $2.5b | $2.5b | $0 | — | — | — | — | — | |
| Income taxes, net of amounts refunded (Note 15) | $98.0m | $50.0m | $21.0m | $136.0m | $111.0m | $76.0m | $112.0m | $69.0m | $269.0m | $98.0m | |
| Increase (Decrease) in Inventories | $463.0m | ($605.0m) | $75.0m | $5.0m | $304.0m | $18.0m | $10.0m | ($223.0m) | ($70.0m) | ($96.0m) | |
| Interest, net of amounts capitalized | $462.0m | $486.0m | $400.0m | $397.0m | $428.0m | $401.0m | $393.0m | $377.0m | $351.0m | $431.0m | |
| Inventory | ($463.0m) | $605.0m | ($75.0m) | ($5.0m) | ($304.0m) | ($18.0m) | ($10.0m) | $223.0m | $70.0m | $96.0m | |
| Inventory Write-down | $3.0m | $35.0m | $8.0m | $11.0m | $233.0m | $0 | $0 | $0 | $0 | $0 | |
| Investments in unconsolidated entities (Note 9) | ($301.0m) | ($416.0m) | ($468.0m) | ($524.0m) | ($461.0m) | ($94.0m) | ($14.0m) | ($33.0m) | ($4.0m) | ($2.0m) | |
| Net borrowings/(repayments) under PAA commercial paper program (Note 11) | ($564.0m) | ($690.0m) | ($123.0m) | $93.0m | $456.0m | ($545.0m) | — | $433.0m | ($40.0m) | $577.0m | |
| Operating Costs and Expenses | $1.2b | $1.2b | $1.3b | $1.3b | $1.1b | $1.1b | $1.3b | $1.4b | $1.8b | $1.2b | |
| Other | $25.0m | $10.0m | $25.0m | $21.0m | ($12.0m) | $8.0m | $16.0m | $20.0m | $17.0m | $15.0m | |
| Proceeds from sales of assets (Note 8) | $654.0m | $1.1b | $1.3b | $77.0m | $429.0m | $881.0m | $60.0m | $328.0m | $13.0m | $81.0m | |
| Proceeds from the issuance of PAA senior notes (Note 11) | $748.0m | — | — | $998.0m | $748.0m | — | — | $0 | $650.0m | $3.0b | |
| Repayment under PAA EPIC credit agreement (Note 11) | — | — | — | — | — | — | — | $0 | $0 | ($1.1b) | |
| Repayments of PAA senior notes (Note 11) | ($175.0m) | ($1.4b) | — | ($1.0b) | ($617.0m) | — | ($750.0m) | ($1.1b) | ($750.0m) | ($1.0b) | |
| Repurchase of Series A preferred units by a subsidiary (Note 12) | — | — | — | — | — | — | — | $0 | $0 | ($333.0m) | |
| Repurchase of common units by a subsidiary (Note 12) | — | — | — | — | ($50.0m) | ($178.0m) | ($74.0m) | — | $0 | ($8.0m) | |
| Settlement of terminated interest rate hedging instruments (Note 13) | ($29.0m) | ($29.0m) | $14.0m | ($55.0m) | ($100.0m) | — | $42.0m | $80.0m | $57.0m | $37.0m | |
| Trade accounts payable and other | $500.0m | $848.0m | ($367.0m) | $1.2b | ($1.3b) | $2.0b | ($830.0m) | ($242.0m) | ($110.0m) | ($337.0m) | |
| Trade accounts receivable and other | ($524.0m) | ($511.0m) | $309.0m | ($1.2b) | $1.4b | ($2.2b) | $649.0m | $213.0m | $112.0m | $207.0m | |
| Derivative, Gain (Loss) on Derivative, Net | ($324.0m) | ($198.0m) | $106.0m | $325.0m | — | — | — | — | — | — | |
| Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax | ($8.0m) | — | — | — | — | — | — | — | — | — | |
| Net Cash Provided by (Used in) Operating Activities | $718.0m | $2.5b | $2.6b | $2.5b | $1.5b | $2.0b | $2.4b | $2.7b | $2.5b | $2.9b | |
| Cash flows from investing activities: | |||||||||||
| Payments to Acquire Property, Plant, and Equipment | $1.3b | $1.0b | $1.6b | $1.2b | $738.0m | $336.0m | $455.0m | $559.0m | $619.0m | $643.0m | |
| Other investing activities | ($3.0m) | ($1.0m) | ($10.0m) | ($13.0m) | $1.0m | ($33.0m) | $44.0m | $1.0m | $4.0m | — | |
| Payments for (Proceeds from) Other Investing Activities | $3.0m | $1.0m | $10.0m | $13.0m | ($1.0m) | $33.0m | ($44.0m) | ($1.0m) | ($4.0m) | — | |
| Net Cash Provided by (Used in) Investing Activities | ($1.3b) | ($1.6b) | ($813.0m) | ($1.8b) | ($1.1b) | $386.0m | ($526.0m) | ($702.0m) | ($875.0m) | ($3.4b) | |
| Cash flows from financing activities: | |||||||||||
| Proceeds from Issuance of Common Stock | — | $1.5b | — | — | — | — | — | — | — | — | |
| Payments for Repurchase of Common Stock | — | — | — | — | — | — | — | — | — | $8.0m | |
| Contributions from noncontrolling interests | — | — | — | $128.0m | $12.0m | $1.0m | $26.0m | $106.0m | $57.0m | $75.0m | |
| Proceeds from Noncontrolling Interests | — | — | — | $128.0m | — | — | — | $106.0m | $57.0m | $75.0m | |
| Other financing activities | ($31.0m) | $5.0m | ($20.0m) | ($53.0m) | $56.0m | ($160.0m) | ($49.0m) | ($88.0m) | ($49.0m) | ($79.0m) | |
| Proceeds from (Payments for) Other Financing Activities | ($31.0m) | $5.0m | ($20.0m) | ($53.0m) | $56.0m | ($160.0m) | ($49.0m) | ($88.0m) | ($49.0m) | ($79.0m) | |
| Net Cash Provided by (Used in) Financing Activities | $578.0m | ($940.0m) | ($1.8b) | ($717.0m) | ($430.0m) | ($2.0b) | ($1.9b) | ($2.0b) | ($1.7b) | $474.0m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | ($10.0m) | $29.0m | ($3.0m) | ($8.0m) | ($5.0m) | ($3.0m) | $49.0m | ($11.0m) | $14.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | $50.0m | $40.0m | $15.0m | ($21.0m) | $393.0m | ($52.0m) | $49.0m | ($104.0m) | ($20.0m) | |
| Net increase/(decrease) in cash and cash equivalents and restricted cash | — | ($10.0m) | $29.0m | $15.0m | ($21.0m) | $393.0m | ($52.0m) | $49.0m | ($104.0m) | ($20.0m) | |
| Cash and cash equivalents and restricted cash, beginning of period | — | $50.0m | $40.0m | $69.0m | $63.0m | $456.0m | $404.0m | $453.0m | $349.0m | $329.0m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | ($10.0m) | $29.0m | $84.0m | $63.0m | $456.0m | $404.0m | $453.0m | $349.0m | $329.0m | |
| Supplemental disclosure of cash flow information: | |||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $462.0m | $486.0m | $400.0m | $397.0m | $428.0m | $401.0m | $393.0m | $377.0m | $351.0m | $431.0m | |
| Income Taxes Paid, Net | $98.0m | $50.0m | $21.0m | $136.0m | $111.0m | $76.0m | $112.0m | $69.0m | $269.0m | $98.0m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.